S

Scholar Rock

Biopharmaceutical firm targeting protein growth factors

Director/Senior Director Medical Affairs

Biology & BiotechPosted on Nov 6
Full-timeZug, SwitzerlandNo salary listed

About the Job

Requirements

  • An advanced degree (Pharm.D., Ph.D., or M.D.) is required.
  • At least 10 years of related work experience in medical affairs industry roles.
  • Ability to think strategically and execute complex initiatives pragmatically with customer focus.
  • Experience executing regional medical initiatives, such as advisory boards and evidence-generation projects.
  • Track record of establishing, building, and maintaining scientific engagement with influential academic and clinical experts.
  • Knowledge of relevant European Union compliance and regulatory guidelines.
  • Ability to summarize complex information and present it clearly, concisely, and accurately to audiences with varying levels of scientific expertise.
  • Ability to work effectively with cross-functional partners and independently, with professional maturity, confidence, and competence.
  • Ability to travel 30–50%; weekend travel may be required based on conference or congress dates.
  • Commitment to follow company values, policies, and ethical and compliance standards.

Responsibilities

  • Co-create the medical strategy with the EMEA Medical Lead and relevant global medical stakeholders, and drive execution of EMEA medical plans in alignment with global strategic priorities.
  • Build partnerships with the external SMA community and actively participate in key academic, research, and clinical-care forums.
  • Lead the strategy, development, and execution of above-market initiatives, including regional advisory boards and preceptorship programs.
  • Serve as a subject-matter expert in medical review processes to support development and localization of EMEA external and field materials.
  • Build and implement engagement and communication plans with internal stakeholders, including global scientific communications teams, and co-lead associated medical education initiatives, such as medical symposia, when applicable.
  • Co-create and define the EMEA real-world evidence (RWE) strategy in alignment with global priorities and execute regional evidence-generation plans in partnership with global and local medical stakeholders.
  • Ensure RWE collaborations are fit for purpose, scientifically and regulatorily rigorous, and produce high-quality, credible evidence that supports stakeholder requirements.
  • Establish and maintain strategic relationships with registry leaders, key opinion leaders, and relevant groups alongside global medical evidence teams, developing long-term collaborations with academic and data consortia.
  • Oversee initiation and delivery of RWE projects with European and EMEA registry and academic partners, ensuring feasibility, timely execution, and measurable impact.
  • Oversee European and EMEA investigator-initiated studies and independent research requests, aligning external research with evidence-generation priorities.
  • Facilitate sharing of best practices and knowledge across the organization and support coordination of insight collection and reporting.

Desired Qualifications

  • Rare disease experience.

About the Company

Scholar Rock

Biopharmaceutical firm targeting protein growth factors

Scholar Rock develops biopharmaceutical therapies by targeting protein growth factors to treat diverse diseases. Its work hinges on a proprietary drug discovery platform that identifies ways to modulate these growth factors, enabling creation of novel therapeutic solutions. The company advances its programs through research and development, and collaborates with other biopharmaceutical companies and research institutions, earning revenue via licensing agreements, milestone payments, and eventual product sales. Scholar Rock differentiates itself by focusing on protein growth factors and pursuing targets and indications that have been historically overlooked, with a strong emphasis on partnerships and patient-centric approaches. The overall goal is to deliver safe and effective therapies that improve patient outcomes by precisely modulating growth factor pathways through collaborative science.

Company size
201-500
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2012

Recently Posted Jobs

Explore more opportunities at Scholar Rock

See more jobs